Protein panel expression analysis showed that AML cells displayed decreased levels of anti-apoptotic BCL-XL (Figure 6C, middle) and uncleaved PARP (Figure 6C, right) in bones but not in spleens of mice treated with NC525. This evidence concerns the gene BCL2L1 and acute myeloid leukemia.